An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
about
A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.Functional interrogation of non-coding DNA through CRISPR genome editing.Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancerAdenoid cystic carcinoma: emerging role of translocations and gene fusionsDown-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway.Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.Genetic Characterization of Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Potential Familial Occurrence in First-Degree Relatives.Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations.MYB-QKI drives childhood brain tumors via tripartite mechanism.Transcriptional Addiction in Cancer.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.Human papillomavirus-related carcinoma with adenoid cystic-like features of the sinonasal tract: clinical and morphological characterization of six new cases.The Varied Roles of Notch in Cancer.A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 (V617F) positive primary myelofibrosis.Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks.Taking it up a NOTCH: a novel subgroup of ACC is identified.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest‐like stemness as a target.Novel insights into chromosomal conformations in cancer.MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast.Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.Reassessing the Potential of Myb-targeted Anti-cancer Therapy.Salivary gland cancer patient-derived xenografts enable characterization of cancer stem cells and new gene fusions associated with tumor progression.Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes.Genetic rearrangements, hotspot mutations, and microRNA expression in the progression of metastatic adenoid cystic carcinoma of the salivary gland.Targeting Super-Enhancers for Disease Treatment and Diagnosis.Patterns and mechanisms of structural variations in human cancer
P2860
Q30252721-16113D00-E24D-40E1-B7B6-55377CBCE185Q33779308-2D8A6F5D-A89C-4722-B188-847D0CB0DF39Q36306820-0A6209F9-43B8-4911-A566-A9D927608440Q36319724-8AD39A90-D6B4-4E66-857D-860867973131Q37662396-87D9E54E-477C-417A-B76E-4F47FB8F8CECQ37732988-0A62BB1E-3414-46C4-9DA3-30503A449334Q38694375-7E569A4E-1FA9-48F7-A829-418383DBBAC5Q38955838-0DA2E09F-92D7-468E-B314-491DEF43611BQ38997020-C7A2B28C-A25D-412B-8B71-C4B8385C4F07Q39100998-3F3FDF2E-20B0-4FE1-AC2F-499D09377E6FQ39130428-D52329A5-8586-4B3D-9B7F-08E8E8408C57Q39441366-9123E2C8-E450-4AB7-8DC2-277BEA9C502DQ40202793-3958E3F9-BA00-4A89-BCEB-4BAB5B875494Q40390616-5C83571E-E4D5-40B6-96B4-78E2016D67FBQ40411894-E8A2BED1-4F75-438A-BD97-37E5F86462E0Q40605505-39567B70-C46B-4B6D-9967-DE4AE5DACDF8Q41004305-CBDF63C2-6D5C-45B3-BE20-57A6EB4AA3ACQ41020733-4940BE09-8589-43C3-A3CF-F873E308AC35Q41194627-3B03D5FA-82B6-44B5-A241-CBC9EADF5481Q42692999-F8399575-AF4B-404C-A306-0ECF84152D60Q46789365-65A8ADB1-AB25-49DB-9884-7A1B7A9398F9Q46831652-F3C26352-511B-49AE-9144-72AD12074E67Q47098649-B4ADEF2D-1626-4887-BF49-313C9B3EF9DCQ47391427-10C08A54-DA36-4A65-99D0-4E515B552A20Q47723106-ECA10C71-4F6F-4E7F-9DBA-F60139FE3A09Q47732435-9B43D37F-CA94-4ECE-936B-982EA513AEE4Q47735648-FF99D3B0-D58A-44BB-A520-F573720BE899Q47796677-19300021-F0D2-4765-84C9-E93889CF6A3BQ47999487-A1CAAE08-44E1-42A8-9B91-EA3DD9463FC2Q50144412-2B2C90C1-3B3A-4B3A-B30D-C2F4D1891158Q50884067-2614C936-2A9B-461B-AE60-B8990F20F859Q52576037-13CD6B29-9505-4842-91D7-0FDF8FBF03E4Q52648065-47D83AA6-E1DB-4137-8EB7-03BE1DD621D6Q52684155-0293457B-ED86-4B7F-8126-1A41244AFB5DQ54955768-7E7AA943-5380-425F-959E-31BCE2A4DEFEQ55454424-9C295234-4E20-4DCD-9E84-3A6067D3E9A1Q58797497-757946A4-EAC8-4532-AB65-7021EB1190F8
P2860
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@ast
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@en
type
label
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@ast
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@en
prefLabel
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@ast
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
@en
P2093
Adel K El-Naggar
Amir H Afrogheh
Birgit Knoechel
Bradley E Bernstein
Christopher A Moskaluk
Christopher D Carey
James E Bradner
Jon C Aster
Kaylyn E Williamson
P2860
P2888
P304
P356
10.1038/NG.3502
P407
P577
2016-02-01T00:00:00Z